Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study

Objective: To evaluate the efficacy and safety of lurasidone in acutely symptomatic adolescent patients with schizophrenia. Methods: Patients aged 13–17 years were randomly assigned to 6 weeks of double-blind, fixed-dose lurasidone (40 or 80 mg/day) or placebo. Primary and key secondary efficacy mea...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Robert, Loebel, Antony, Cucchiaro, Josephine, Deng, Ling, Findling, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568017/
https://www.ncbi.nlm.nih.gov/pubmed/28475373
http://dx.doi.org/10.1089/cap.2016.0189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568017/
https://www.ncbi.nlm.nih.gov/pubmed/28475373
http://dx.doi.org/10.1089/cap.2016.0189

Ejemplares similares